Literature DB >> 2844968

Mutational analysis of the herpes simplex virus type 1 trans-inducing factor Vmw65.

C I Ace1, M A Dalrymple, F H Ramsay, V G Preston, C M Preston.   

Abstract

The herpes simplex virus type 1 (HSV-1) polypeptide Vmw65 is a structural component of the virus particle and is also responsible for trans-induction of immediate early (IE) transcription. Functional domains of this polypeptide were investigated by constructing a series of 10 plasmids each with a 12 bp insertion in the gene encoding Vmw65. Plasmids were analysed for their ability to stimulate IE transcription in short term transfection assays, and the altered Vmw65 polypeptides were assayed for the ability to form an IE-specific protein-DNA complex (IEC) in vitro. A direct correlation was observed between stimulation of transcription and formation of IEC, strongly suggesting that IEC is an important intermediate in transcription activation. Plasmids were also tested for their ability to rescue the temperature-sensitive mutation in the HSV-2 assembly mutant ts2203, since marker rescue analysis indicated that this mutation maps within the gene encoding Vmw65. Five plasmids failed to rescue ts2203, thereby defining regions of Vmw65 required for virus assembly. The results show that distinct domains exist in Vmw65 for activation of transcription and assembly of virus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844968     DOI: 10.1099/0022-1317-69-10-2595

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  55 in total

1.  A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells.

Authors:  P J Desai
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway.

Authors:  M D Koffa; J B Clements; E Izaurralde; S Wadd; S A Wilson; I W Mattaj; S Kuersten
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0.

Authors:  K L Mossman; J R Smiley
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 produces a phenotype similar to that of the in1814 linker insertion mutation.

Authors:  J R Smiley; J Duncan
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Differences in determinants required for complex formation and transactivation in related VP16 proteins.

Authors:  M Grapes; P O'Hare
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis.

Authors:  C M Preston; M J Nicholl
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.

Authors:  J I Cohen; K Seidel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.

Authors:  G D Elliott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing factor.

Authors:  V Misra; A C Bratanich; D Carpenter; P O'Hare
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.

Authors:  P R Kinchington; J P Vergnes; P Defechereux; J Piette; S E Turse
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.